Publication & Citation Trends
Most Cited Works
Publications
110 total
TIGIT is the central player in T-cell suppression associated with CAR T-cell relapse in mantle cell lymphoma PDF
Cited by 72
OpenAlex
Establishment of a Patient-Derived Organoid Culture Platform for Mantle Cell Lymphoma Drug Sensitivity and CAR T Cell Anti-Tumor Activity Assay OA
Cited by 1
Semantic Scholar
HSP27 Promotes Mantle Cell Lymphoma Growth and Mediates Resistance to Venetoclax OA
Cited by 1
Semantic Scholar
Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma PDF
Cited by 62
OpenAlex
Dynamic Reprogramming and Evolution Associated with Sequential Resistance to Ibrutinib and CAR T Therapy in Mantle Cell Lymphoma OA
Cited by 0
Semantic Scholar
Abstract 1112: Exploiting oncogene-conferred glutamine addiction as a therapeutic vulnerability in resistant mantle cell lymphoma
Cited by 0
Semantic Scholar
Abemaciclib in Combination with Copanlisib to Overcome Therapeutic Resistance in Mantle Cell Lymphoma OA
Cited by 1
Semantic Scholar
Pirtobrutinib Overcomes Ibrutinib and Venetoclax Resistance in Mantle Cell Lymphoma OA
Cited by 4
Semantic Scholar
Research Topics
Lymphoma Diagnosis and Treatment
(48)
Chronic Lymphocytic Leukemia Research
(32)
CAR-T cell therapy research
(24)
NF-κB Signaling Pathways
(8)
interferon and immune responses
(6)
Frequent Co-Authors
Affiliations
The University of Texas MD Anderson Cancer Center
University of Kansas
Oregon Health & Science University
Baylor College of Medicine
Virginia Commonwealth University